NERx Biosciences
IN - IndianapolisBiotechnology
Focus: NERx Biosciences is a generic and specialty pharmaceutical company founded in 2009, headquartered in Indianapolis, with a portfolio focused on post-LOE small molecules across cardiovascular, gastrointestinal, and other therapeutic areas.
Profile data last refreshed 2d ago · AI intelligence enriched 2w ago
Open Jobs
0
About NERx Biosciences
AI assessmentNot HiringNo open roles listed right now. Follow NERx Biosciences to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$286K Part DDeclining
Post-LOE
Represents 100% of company revenue but with minimal Part D spending, indicating marginal market presence or niche specialty use.
Help build intelligence for NERx Biosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.